by ComplianceQuest

My Dashboard Inspection Tracker FDA Guidance Templates Assessments

Sign in Get started

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

ANALYTICS

Tracker Overview Enforcement Themes

FDA ACTIONS

Form 483s Warning Letters Inspections Recalls

AUDIT READINESS

COMPANIES

Companies Facilities

Loading…

Dashboard Warning LettersWarning Letter Details

TCI Co., Ltd BioCosme PABP BRANCH Warning Letter Details

Warning Letter

TCI Co., Ltd BioCosme PABP BRANCH

TCI Co., Ltd BioCosme PABP BRANCH, 8F, No. 187, Gangqian Rd. Neihu District , Taipei City 11494 Taiwan

Issue DateSeptember 02, 2026

FEI Number3014217121

Violations6

CountryTaiwan

Issuing Office

Center for Drug Evaluation and Research (CDER)

Product Type

Drugs

Status

Open

Subject

CGMP/Finished Pharmaceuticals/Adulterated

TCI Co., Ltd BioCosme PABP BRANCH FDA Warning Letter, September 2, 2026